Dimensional Fund Advisors LP Global Blood Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$32.4 - $68.18 $36,838 - $77,520	-1,137 Reduced 1.27%	88,277 $6.01 Million
Q2 2022 Aug 12, 2022	SELL	$22.3 - $37.39 $9.84 Million - $16.5 Million	-441,279 Reduced 83.15%	89,414 $2.86 Million
Q1 2022 May 13, 2022	BUY	$25.68 - $35.59 $2.85 Million - $3.96 Million	111,130 Added 26.49%	530,693 $18.4 Million
Q4 2021 Feb 09, 2022	BUY	$24.9 - $40.26 $2.02 Million - $3.26 Million	81,056 Added 23.95%	419,563 $12.3 Million
Q3 2021 Nov 12, 2021	SELL	$25.48 - $37.34 $1.58 Million - $2.32 Million	-62,145 Reduced 15.51%	338,507 $8.63 Million
Q2 2021 Aug 12, 2021	BUY	$32.46 - $43.42 $751,319 - $1 Million	23,146 Added 6.13%	400,652 $14 Million
Q1 2021 May 14, 2021	SELL	$38.94 - $50.85 $1.27 Million - $1.66 Million	-32,612 Reduced 7.95%	377,506 $15.4 Million
Q4 2020 Feb 25, 2021	BUY	$37.65 - $63.77 $15.4 Million - $26.2 Million	410,118 New	410,118 $17.8 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.